Title,team,doi_pre,doi_pub,date_added_preprint,date_added_publication,source_preprint,source_publication,original,notes,Preprint in SF tracker,publication in SF tracker,apc_amount,apc_status,OpenAlex_ID
Alpha-synuclein aggregates are phosphatase resistant,Kordower,10.1101/2023.11.20.567854,10.1186/s40478-024-01785-0,2024-05-31 00:00:00,2024-06-11 00:00:00,comp; works,works,1,,1.0,1,3665.0,Paid,W4399230878
Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease,Sulzer,10.1101/2022.10.12.511960,10.1038/s41467-023-39060-w,before_doi_tracker,before_doi_tracker,before_doi_tracker,before_doi_tracker,1,,1.0,1,,,W4382059965
Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older,PPMI,missing,10.1212/WNL.0000000000207077,missing,before_doi_tracker,missing,before_doi_tracker,1,,,1,,,W4322489360
Insights into Ancestral Diversity in Parkinson’s Disease Risk: A Comparative Assessment of Polygenic Risk Scores,GP2,10.1101/2023.11.28.23299090,10.1038/s41531-025-00967-4,2024-05-31 00:00:00,2025-08-22 00:00:00,works,biorxiv linked,1,,1.0,,,,W4412008894
Multi-ancestry population attributable risk assessment of common genetic variation in Alzheimer’s and Parkinson’s diseases,GP2,10.1101/2024.09.23.24314240,,2025-01-03 00:00:00,,gp2,NA_not_yet_published,1,,1.0,,,,W4402830588
LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization,PPMI,10.1101/2024.07.22.24310806,10.1093/braincomms/fcaf103,2025-03-28 00:00:00,2025-03-28 00:00:00,oa_report,oa_report,1,,1.0,1,,,W4408207574
Neuronal alpha-Synuclein Disease stage progression over five years,PPMI,10.1101/2024.12.17.24319172,,2025-03-28 00:00:00,,comp,NA_not_yet_published,1,,1.0,,,,W4405729494
Contralateral spread of unilateral tremor in Parkinson’s Disease,PPMI,10.1101/2025.02.20.25322608,,2025-03-28 00:00:00,,comp,NA_not_yet_published,1,,1.0,,,,W4407823527
